Has Amy Licata received payments from drug or device companies?

Yes. Drug and device makers reported $2,832 in general payments to Amy Licata across 117 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amy Licata did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amy Licata come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amy Licata

Adult Health · West Reading, PANPI 1255393054

Payments from drug & device makers

$2,832in general payments, 2019–2025

Across 117 payments — averaging $24.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

E.r. Squibb & Sons, L.L.C.$855
Pfizer$558
Johnson & Johnson$360
AstraZeneca$311
Madrigal Pharmaceuticals$150
Novartis$136
plus $463 from 7 others

What the payments were for

Food & beverage$2,75797%
Education$753%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	38	$855
Pfizer	30	$558
Johnson & Johnson	13	$360
AstraZeneca	14	$311
Madrigal Pharmaceuticals	1	$150
Novartis	8	$136
Boston Scientific	1	$125
Lantheus Medical Imaging, Inc.	1	$99
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	5	$85
Scpharmaceuticals Inc.	3	$62
Impulse Dynamics (USA) Inc.	1	$45
Abbott	1	$25
Eisai Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,832 in reported general payments places this provider in the 85th percentile of 899 adult health providers in Pennsylvania.

See all adult health providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$31,906

Medicare patients

272

Services billed

316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	106	$105,615
Repatha SureclickEvolocumab	48	$53,858
BrilintaTicagrelor	71	$52,167
EntrestoSacubitril/Valsartan	23	$25,835
XareltoRivaroxaban	25	$20,192
Praluent PenAlirocumab	15	$18,247
JardianceEmpagliflozin	12	$9,312
Metoprolol Succinate	266	$4,043
Ezetimibe	92	$3,840
Atorvastatin Calcium	253	$3,504
ClopidogrelClopidogrel Bisulfate	225	$3,016
Ranolazine ErRanolazine	15	$2,303
Rosuvastatin Calcium	103	$1,905
Losartan Potassium	95	$1,670
Amlodipine Besylate	165	$1,337

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$558	$105,615106 claims
AstraZenecaBrilinta	$311	$52,16771 claims
NovartisEntresto	$136	$25,83523 claims
Johnson & JohnsonXarelto	$360	$20,19225 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 899 adult health providers in Pennsylvania.